MedPath

E-Nose: Diagnostic Tool for Pleural TB

Not Applicable
Conditions
Tuberculosis, Pleural
Registration Number
NCT02765087
Lead Sponsor
Universidad Central de Venezuela
Brief Summary

The purpose of this study is to determine the diagnostic utility of the device 'Electronic Nose' for Pleural TB, which is a Extra pulmonary TB form, compared with pleural biopsy, the current gold standard.

Detailed Description

The aim of the study is to determine the diagnostic utility of the device 'Electronic Nose' for Pleural TB, which is a Extra pulmonary TB form.

The patient who qualified for the study, according to the inclusion criteria, after consenting, will be guided through and oriented survey for risk factors, then a complete physical exam, and after that, the patient will breathe for 5 minutes trough the device, which stores the patient information, that later will be download to a computer and will be send to the server's manufacturer company, in Netherlands.

During and after the use of the device, investigators determine the adverse effects of the intervention, according to the CTCEA.

Investigators use the pleural biopsy, which is the gold standard, to determine the diagnostic utility of the test. And, will compare the results with other tests currently perform as the regular diagnostic routine, such as Chest CT, adenosine deaminase value of pleural fluid and cytomorphologic \& cytochemistry of the pleural fluid.

Patient Registries will be keep in an electronic database, as well as handwriting history, with the backup copy in the records of the hospital in which the patient was admitted.

Auditories will be realised by the Ethics Committee in different time frames.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria
  1. Severe compromise of the general condition
  2. Not capable to exhaled through the E-nose.
  3. No possibility to follow-up.
  4. By discretion of the research team.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Sensitivity and Specificity of the device for the diagnosis of Tuberculosis Pleural effusion1 year
Secondary Outcome Measures
NameTimeMethod
Adverse Effects related to the use of the device, according to the CTCEA1 year

Trial Locations

Locations (1)

Instituto de Biomedicina

🇻🇪

Caracas, DC, Venezuela

Instituto de Biomedicina
🇻🇪Caracas, DC, Venezuela
Sergio Poli, MD
Sub Investigator
Jacobus de Waard, PhD.
Principal Investigator
Luisa Quesada, MD
Sub Investigator
Emines Salas, BsBio
Sub Investigator
Fernando Poli, MD
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.